These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3424075)

  • 1. [Primary radiotherapy of prostatic carcinoma--the results at Essen with 173 patients].
    Müller RD; Czeglarski G; Bamberg M; Budach V
    Strahlenther Onkol; 1987 Dec; 163(12):755-63. PubMed ID: 3424075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors in prostatic carcinoma treated with radical radiotherapy: stages A, B, and C].
    Rodríguez Villalba S; Magallón Sebastián R; Regueiro Otero C; Rodríguez Reina G; Romero Fernández J; Carballido Rodríguez J; De la Torre Tomás A; Aragón de la Cruz G
    Actas Urol Esp; 1996 Apr; 20(4):336-45. PubMed ID: 8801794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer of the prostate. Results and causes of failure after exclusive radiotherapy in 131 cases treated at in locoregional stage between 1972 and 1981].
    Pourquier H; Dubois JB; Hay M; Bons F; Guiter J; Amar E; Averous M; Navratil H; Grasset D
    J Urol (Paris); 1986; 92(9):593-600. PubMed ID: 3102619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The results of primary HDR-afterloading brachytherapy in corpus carcinoma].
    Knocke TH; Kucera H; Weidinger B; Höller W; Pötter R
    Strahlenther Onkol; 1995 Apr; 171(4):195-201. PubMed ID: 7740406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control.
    Syndikus I; Pickles T; Kostashuk E; Sullivan LD
    J Urol; 1996 Jun; 155(6):1983-6. PubMed ID: 8618303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.
    Vargas C; Martínez A; Galalae R; Demanes J; Harsolia A; Schour L; Nuernberg N; Gonzalez J
    Prostate Cancer Prostatic Dis; 2006; 9(3):245-53. PubMed ID: 16786040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
    Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
    Tullio A; Marchetti C; Sesenna E; Brusati R; Cocchi R; Eusebi V
    J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant tumors of the nasal cavity and paranasal sinuses.
    Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
    Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.
    Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD
    Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
    Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
    Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Definitive radical radiotherapy in tumors of the prostate. Analysis of statistics].
    Fumagalli M; Personeni A; Vavassori V; Bianchi N
    Radiol Med; 1988 Jun; 75(6):647-52. PubMed ID: 3291007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.